{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:07:40Z","timestamp":1788869260790,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82570194"],"award-info":[{"award-number":["82570194"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270233"],"award-info":[{"award-number":["82270233"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2023ZD0502400"],"award-info":[{"award-number":["2023ZD0502400"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515011659"],"award-info":[{"award-number":["2024A1515011659"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.clml.2026.08.007","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T23:40:32Z","timestamp":1787269232000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of the Characteristics and Prognostic Impact of t(3;5)(q25;q35)\/NPM1::MLF1 Fusion Genes and NPM1 Mutations in Acute Myeloid Leukemia Patients"],"prefix":"10.1016","author":[{"given":"Jielei","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yili","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clml.2026.08.007_bib0001","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/1097-0142(197608)38:2<748::AID-CNCR2820380218>3.0.CO;2-U","article-title":"Chromosomes and causation of human cancer and leukemia. XVII. Banding studies in acute myeloblastic leukemia (AML)","volume":"38","author":"Oshimura","year":"1976","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.clml.2026.08.007_bib0002","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cancergencyto.2010.02.009","article-title":"Detection of t(3;5) and NPM1\/MLF1 rearrangement in an elderly patient with acute myeloid leukemia: clinical and laboratory study with review of the literature","volume":"199","author":"Lim","year":"2010","journal-title":"Cancer Genet Cytogenet"},{"issue":"3","key":"10.1016\/j.clml.2026.08.007_bib0003","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","article-title":"Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials","volume":"116","author":"Grimwade","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.clml.2026.08.007_bib0004","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2012.082149","article-title":"Acute myeloid leukemia with translocation t(3;5): new molecular insights","volume":"98","author":"Dumezy","year":"2013","journal-title":"Haematologica"},{"issue":"20","key":"10.1016\/j.clml.2026.08.007_bib0005","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.clml.2026.08.007_bib0006","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.clml.2026.08.007_bib0007","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.clml.2026.08.007_bib0008","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0046-8177(03)00251-X","article-title":"Detection of NPM\/MLF1 fusion in t(3;5)-positive acute myeloid leukemia and myelodysplasia","volume":"34","author":"Arber","year":"2003","journal-title":"Human Pathol"},{"issue":"1","key":"10.1016\/j.clml.2026.08.007_bib0009","first-page":"42","article-title":"Clinicopathologic manifestations and breakpoints of the t(3;5) in patients with acute nonlymphocytic leukemia","volume":"3","author":"Raimondi","year":"1989","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.clml.2026.08.007_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008463","article-title":"NPM and NPM-MLF1 interact with chromatin remodeling complexes and influence their recruitment to specific genes","volume":"15","author":"Darracq","year":"2019","journal-title":"PLOS Genetics"},{"issue":"9","key":"10.1016\/j.clml.2026.08.007_bib0011","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/ajh.27284","article-title":"Myeloid neoplasm with <10% blasts and t(3;5)(q25.1;q34)\/NPM::MLF1: a classification dilemma","volume":"99","author":"Sameeta","year":"2024","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.clml.2026.08.007_bib0012","doi-asserted-by":"crossref","first-page":"149","DOI":"10.15264\/cpho.2014.21.2.149","article-title":"A pediatric case of acute myeloid leukemia with t(3;5)(q25;q34)","volume":"21","author":"Bo","year":"2014","journal-title":"Clin Pediatr Hematol Oncol"},{"issue":"1","key":"10.1016\/j.clml.2026.08.007_bib0013","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1365-2141.1993.tb04647.x","article-title":"Clinical, haematological and cytogenetic features in 24 patients with structural rearrangements of the Q arm of chromosome 3","volume":"83","author":"Grigg","year":"1993","journal-title":"Br J Haematol"},{"issue":"20","key":"10.1016\/j.clml.2026.08.007_bib0014","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1182\/bloodadvances.2019000404","article-title":"Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia","volume":"3","author":"Shiba","year":"2019","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.clml.2026.08.007_bib0015","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/pbc.21874","article-title":"Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?","volume":"52","author":"Veltroni","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"10.1016\/j.clml.2026.08.007_bib0016","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/MPH.0b013e31815814c9","article-title":"Early acute myeloblastic leukemia treatment for childhood myelodysplastic syndrome with t(3;5) (NPM\/MLF1)","volume":"29","author":"Sevilla","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"issue":"12","key":"10.1016\/j.clml.2026.08.007_bib0017","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.clml.2026.08.007_bib0018","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1182\/blood.V80.11.2873.2873","article-title":"Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia","volume":"80","author":"Olopade","year":"1992","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.clml.2026.08.007_bib0019","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1182\/blood.V120.21.1456.1456","article-title":"Incidence and outcomes of a rare translocation t(3,5) in patients (pts) with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)","volume":"120","author":"Alattar","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.clml.2026.08.007_bib0020","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/sj.leu.2403688","article-title":"Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries","volume":"19","author":"Chen","year":"2005","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.clml.2026.08.007_bib0021","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.leu.2404063","article-title":"Loss of the NPM1 gene in myeloid disorders with chromosome 5 rearrangements","volume":"20","author":"Berger","year":"2006","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.clml.2026.08.007_bib0022","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1038\/s41375-022-01631-z","article-title":"AML, NOS and AML-MRC as defined by multilineage dysplasia share a common mutation pattern which is distinct from AML-MRC as defined by MDS-related cytogenetics","volume":"36","author":"Fuhrmann","year":"2022","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.clml.2026.08.007_bib0023","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3324\/haematol.2021.278436","article-title":"Fusion gene detection by RNA-sequencing complements diagnostics of acute myeloid leukemia and identifies recurring NRIP1-MIR99AHG rearrangements","volume":"107","author":"Kerbs","year":"2022","journal-title":"Haematologica (Roma)"},{"issue":"3","key":"10.1016\/j.clml.2026.08.007_bib0024","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2141.2004.05038.x","article-title":"Classical and molecular cytogenetic abnormalities and outcome of childhood acute myeloid leukaemia: report from a referral centre in Israel","volume":"126","author":"Stark","year":"2004","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.clml.2026.08.007_bib0025","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jmoldx.2014.05.004","article-title":"Development of an NPM1\/MLF1D-FISH probe set for the detection of t(3;5)(q25;q35) identified in patients with acute myeloid leukemia","volume":"16","author":"Aypar","year":"2014","journal-title":"J Mol Diagn"},{"issue":"3","key":"10.1016\/j.clml.2026.08.007_bib0026","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ajh.26812","article-title":"Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia","volume":"98","author":"Falini","year":"2023","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.clml.2026.08.007_bib0027","first-page":"265","article-title":"The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1","volume":"12","author":"Yoneda-Kato","year":"1996","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.clml.2026.08.007_bib0028","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1038\/sj.emboj.7600656","article-title":"Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9 signalosome subunit 3","volume":"24","author":"Yoneda-Kato","year":"2005","journal-title":"EMBO J"},{"issue":"3","key":"10.1016\/j.clml.2026.08.007_bib0029","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1537-2995.2008.02008.x","article-title":"Synchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case with comments on donor evaluation","volume":"49","author":"Glasser","year":"2009","journal-title":"Transfusion"},{"issue":"01","key":"10.1016\/j.clml.2026.08.007_bib0030","article-title":"One case of acute myeloid leukemia with positive NPM1::MLF1 fusion gene","volume":"08","author":"Qiu","year":"2026","journal-title":"Chinese Clin Case Res Database"},{"issue":"7","key":"10.1016\/j.clml.2026.08.007_bib0031","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1038\/s41375-025-02634-2","article-title":"Characteristics and outcomes of newly diagnosed acute myeloid leukemia with KMT2Arearrangements","volume":"39","author":"Bataller","year":"2025","journal-title":"Leukemia."},{"issue":"4","key":"10.1016\/j.clml.2026.08.007_bib0032","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/ajh.27600","article-title":"Biology and management of acute myeloid leukemia with mutated NPM1","volume":"100","author":"Chen","year":"2025","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.clml.2026.08.007_bib0033","first-page":"152","article-title":"Research advances on menin inhibitors in treatment of acute myeloid leukemia","volume":"53","author":"Su","year":"2026","journal-title":"Cancer Res Prev Treat"},{"issue":"23","key":"10.1016\/j.clml.2026.08.007_bib0034","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1200\/JCO-25-00914","article-title":"Azacitidine, venetoclax, and revumenib for newly diagnosed NPM1-mutated or KMT2A-rearranged AML","volume":"43","author":"Zeidner","year":"2025","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clml.2026.08.007_bib0035","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3390\/cancers15041177","article-title":"NPM 1 mutations in AML-the landscape in 2023","volume":"15","author":"Sharma","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.clml.2026.08.007_bib0036","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/leu.2017.200","article-title":"DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemia","volume":"32","author":"Gaidzik","year":"2018","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.clml.2026.08.007_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.clml.2021.07.011","article-title":"Prognostic impact of concurrent DNMT3A, FLT3 and NPM1 gene mutations in acute myeloid leukemia patients","volume":"21","author":"Elrhman","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2026.08.007_bib0038","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13045-014-0074-4","article-title":"Clinical features of de novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations","volume":"7","author":"Loghavi","year":"2014","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.clml.2026.08.007_bib0039","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/leu.2013.236","article-title":"Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia","volume":"28","author":"Hou","year":"2014","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.clml.2026.08.007_bib0040","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.leukres.2013.07.032","article-title":"DNMT3A mutation is a poor prognosis biomarker in AML: results of a meta-analysis of 4500 AML patients","volume":"37","author":"Shivarov","year":"2013","journal-title":"Leuk Res"},{"issue":"3","key":"10.1016\/j.clml.2026.08.007_bib0041","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMoa041974","article-title":"Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype","volume":"352","author":"Falini","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265026002685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265026002685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:19:39Z","timestamp":1788866379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265026002685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":41,"alternative-id":["S2152265026002685"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2026.08.007","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of the Characteristics and Prognostic Impact of t(3;5)(q25;q35)\/NPM1::MLF1 Fusion Genes and NPM1 Mutations in Acute Myeloid Leukemia Patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2026.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}